Skip to main content

Rheumatoid Arthritis: Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (Reccomended for eMeasure Trial Approval)

CBE ID
2525
Endorsement Status
Approved for Trial Use
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Spring 2019
Is Under Review
No
Next Maintenance Cycle
Fall 2025
1.3 Measure Description

Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who are newly prescribed disease modifying anti-rheumatic drug (DMARD) therapy within 12 months.

    • 1.14 Numerator

      Patient received a DMARD

    • 1.15 Denominator

      Patient age 18 years and older with a diagnosis of rheumatoid arthritis seen for two or more face-to-face encounters for RA with the same clinician during the measurement period

    • Exclusions

      Patients with a diagnosis of HIV; patients who are pregnant; or patients with inactive Rheumatoid Arthritis.

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Approved for Trial Use Primary Care and Chronic Illness Spring Cycle 2019
      Initial Endorsement
      Last Updated
    • Steward
      American College of Rheumatology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      Copyright (c) 2013, American College of Rheumatology

    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off